Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry
Emilio J. Laserna‐Mendieta(Hospital General de Tomelloso), Alfredo J. Lucendo(Hospital General de Tomelloso), Danila Guagnozzi(Hebron University), Antonia Perelló, Sergio Casabona, Esther Rey‐Iborra, Antonio Guardiola‐Arévalo, Anne Lund Krarup(Aalborg University Hospital), Javier Alcedo, Edoardo Savarino(University of Padua), Ángel Arias(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), S. Riva, Jesús Barrio, Cecílio Santander
Cited by 130
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
|Gastroenterology|2014|487
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
|Nature Communications|2020|283